Keranat (Millet/Wheat Ceramides).

Biotin is the cofactor for the carboxylases that run fatty acid and branched-chain amino acid metabolism, both of which supply hair follicle keratinocytes. It is the conventional partner in millet-oil hair formulas.

Zinc is required by the metalloenzymes and transcription factors that drive keratinocyte turnover in the follicle. Structures with fast protein turnover show low zinc status first, which is why it is formulated alongside follicle-directed lipids.

Hair keratin is cross-linked through disulfide bonds, so cysteine is the limiting amino acid for fibre formation. It is the substrate side of any follicle-support formula.

Acylceramide, the barrier lipid that anchors the lamellar structure of the stratum corneum, carries a linoleate ester on its omega-hydroxy fatty acid chain. Without dietary linoleate that ester cannot be formed and the barrier lipid composition shifts. A plant ceramide preparation supplies the sphingoid backbone class; linoleate supplies the esterified partner. Both are settled skin lipid biochemistry, not a claim about a tested combination.

Plant ceramides and miliacin are lipid-soluble and are absorbed through the mixed-micelle route rather than freely. A lipid vehicle in the capsule, or a meal containing fat, provides the bile-salt-and-lipid environment that route needs. Softgel formats use this exact logic. Absorption chemistry only.

Lecithin phospholipids emulsify a lipid extract into a dispersible form and participate in micelle formation. Sunflower lecithin is also rich in linoleate, which is the fatty acid esterified into skin acylceramides. So it does two jobs in a ceramide formula, one physical and one compositional. Neither is a clinical claim.

Hyaluronan is a dermal glycosaminoglycan that binds water in the extracellular matrix; ceramides sit in the stratum corneum lipid lamellae. They occupy different compartments of the same tissue, which is the usual rationale for putting them in one formula. The pairing is composition logic rather than a measured combined effect. Recorded as promising on that basis.

Collagen peptides supply glycine, proline and hydroxyproline plus the di- and tripeptides absorbed intact, feeding the dermal matrix. Ceramides address the outer lipid barrier. Skin formulas combine them because the targets do not overlap. No combination trial is cited here.

Prolyl 4-hydroxylase and lysyl hydroxylase need ascorbate to keep their iron centre reduced through the catalytic cycle. Without it, procollagen chains are under-hydroxylated and the triple helix is unstable. In a skin formula this is the cofactor that makes a structural protein claim coherent. Settled biochemistry, no citation required.

De novo sphingolipid synthesis begins with serine palmitoyltransferase and proceeds through an NADPH-dependent reduction to sphinganine. Niacinamide feeds the pyridine nucleotide pool that supplies those cofactors. The link is real biochemistry read at the pathway level rather than a demonstrated dietary effect. Confidence is set at strong for that reason.

Every ceramide the body makes de novo starts with serine condensing with palmitoyl-CoA. Serine is therefore the backbone donor for the whole sphingolipid class. Supplying dietary ceramides and supplying the substrate for endogenous synthesis are two different routes to the same lipid class. This is textbook pathway chemistry.

Lysyl oxidase is a copper-dependent amine oxidase that forms the covalent cross-links giving collagen and elastin their tensile properties. A skin formula built on structural proteins needs that cofactor present. Copper also competes with zinc for absorption, so the ratio in a formula matters. Both points are established mineral pharmacology.

Orthosilicic acid is associated in nutritional reviews with connective tissue matrix formation, and choline-stabilised forms are used in skin and hair formulas for that reason. The mechanistic detail is less settled than for the classical cofactors. Its presence alongside a ceramide is composition logic. Marked promising rather than established.

A cold-pressed or CO2-extracted seed oil carries unsaturated fatty acids that oxidise on exposure to oxygen and light. Tocopherol is the chain-breaking antioxidant used to slow that in the capsule itself. This is stability chemistry inside the product, distinct from any physiological claim. It also means the two are almost always co-present whether or not the label leads with it.

GLA sits downstream of linoleate on the n-6 pathway and bypasses the delta-6 desaturase step. Formulas aimed at skin barrier lipids use it alongside ceramide sources for that reason. The pathway position is settled; whether the bypass changes barrier composition measurably in people is a separate question. Read it as pathway logic.

Evening primrose oil is the standard dietary GLA source and appears repeatedly beside plant ceramides in skin formulas. Both are lipid formats, so they share a softgel and a vehicle. The pairing is commercial practice supported by pathway chemistry. No combination trial is cited.

Astaxanthin is a xanthophyll carotenoid that needs the same lipid vehicle a ceramide oil provides, so the two travel well in one softgel. Its antioxidant chemistry also slows peroxidation of the unsaturated oil around it. Two functions, both physical and chemical. Nothing here is an outcome claim for the pair.

Psyllium raises luminal viscosity and binds bile acids, both of which slow micellar uptake of fat-soluble material. A ceramide-and-triterpene oil depends on that exact route. Taking the two at the same sitting works against the lipid format. Separating them by a couple of hours is the ordinary handling.

Hair matrix keratinocytes are among the fastest-dividing cells in the body and depend on iron-requiring ribonucleotide reductase for DNA synthesis. Iron status is therefore routinely checked in hair-focused nutrition. A millet ceramide preparation addresses a different part of the picture. The two are complementary rather than interacting.